semaglutide and alopecia Now Ozempic patients say they're going BALD while on fat-loss shot Understanding Hair Loss Associated with

However, they did not find a connection between higher midlife BMI and steeper cognitive decline over time

Semaglutide and tirzepatide are two non-invasive, effective weight loss injections that can help you feel more in control during your journey to a new you

It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved

10.1016/j.chom.2023.03.020 57 Reis-BarbosaP

Clinical judgement and individualised assessment are essential when considering any pharmacological intervention